Company Filing History:
3 out of 1,210 
2 out of 2,967 
1 out of 1,373 
Years Active: 2005-2021
Title: Massimo Loda: Innovator in Cancer Diagnostics
Introduction
Massimo Loda is a prominent inventor based in Belmont, MA (US). He has made significant contributions to the field of cancer diagnostics, particularly in prostate cancer and urothelial carcinoma. With a total of 3 patents, Loda's work focuses on innovative methods for diagnosing and treating cancer.
Latest Patents
One of Loda's latest patents is titled "Compositions and methods for diagnosing prostate cancer using a gene expression signature." This invention relates to the identification of a gene expression signature that predicts the likelihood of prostate cancer metastasizing. The method provided allows for determining whether prostate cancer in a subject will metastasize, along with compositions and kits that include a prostate cancer-associated gene.
Another significant patent is "Chromosome copy number gain as a biomarker of urothelial carcinoma lethality." This patent offers diagnostic assays for classifying cancer patients based on the presence of a copy number gain of specific chromosome regions. The findings indicate that such gains are associated with a less favorable prognosis for patients.
Career Highlights
Massimo Loda has worked with esteemed institutions such as Dana-Farber Cancer Institute and Harvard College. His research has been pivotal in advancing the understanding of cancer diagnostics and treatment options.
Collaborations
Loda has collaborated with notable colleagues, including Frank McKeon and Annie Yang. Their combined expertise has contributed to the development of innovative cancer diagnostic methods.
Conclusion
Massimo Loda's contributions to cancer diagnostics through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to impact the diagnosis and treatment of cancer, showcasing the importance of innovation in healthcare.